BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33400246)

  • 1. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
    Guo T; Yuan D; Zhang W; Zhu D; Xiao A; Mao G; Jiang W; Lin M; Wang J
    Hum Cell; 2021 Mar; 34(2):579-587. PubMed ID: 33400246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
    Chao H; Zhang M; Hou H; Zhang Z; Li N
    Life Sci; 2020 Feb; 243():117296. PubMed ID: 31935390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (
    Zhou Y; Li J; Yang X; Song Y; Li H
    Bioengineered; 2021 Dec; 12(2):12003-12022. PubMed ID: 34787052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
    Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.
    Xia X; Li Z; Li Y; Ye F; Zhou X
    J Gynecol Oncol; 2022 Nov; 33(6):e81. PubMed ID: 36335987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.
    Gu H; Lin R; Zheng F; Zhang Q
    J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 15. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA GASL1 restrains gastric carcinoma cell proliferation and metastasis by sponging microRNA-106a.
    Liu D; Xiao P; Feng C; Meng H; Bi E
    Cell Cycle; 2020 Oct; 19(20):2611-2621. PubMed ID: 32897806
    [No Abstract]   [Full Text] [Related]  

  • 17. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IncRNA XIST Promotes Cardiac Fibrosis in Mice with Diabetic Nephropathy via Sponging miR-106a-5p to Target RUNX1.
    Xu J; Li J; Xu X; Chen P; Wang Q; Li A; Ren Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):55-66. PubMed ID: 36734857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.
    Peng J; Liu F; Zheng H; Wu Q; Liu S
    J Cell Mol Med; 2020 Jan; 24(2):1437-1450. PubMed ID: 31851778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.
    Meng Q; Li Z; Pan J; Sun X
    Hum Cell; 2020 Oct; 33(4):1240-1251. PubMed ID: 32749665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.